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ABSTRACT 
Objective: This research aims to develop a quercetin microemulsion system to improve the solubility of quercetin and to study the stability of the 
microemulsions. 
Methods: The microemulsion is prepared by water titration method using isopropyl myristate (oil), Tween 60®/Span 80® (3:2) (surfactant) and 
ethanol (co-surfactant). Two different aqueous phases, water or NaCl solution, were used to prepare microemulsions and the influence of each 
parameter was described. DPPH scavenging and anti-tyrosinase activity were performed along with chemical stability to evaluate the functional 
stability of microemulsions. 
Results: The influence of percentage of oil phase (variable A) on the solubility of quercetin was less significant than that of percentage of 
surfactant/co-surfactant (variable B). Compared to those prepared with water (variable C), the solubility of quercetin in microemulsions prepared 
with NaCl solution significantly increased. The ratio of the high level to low level for solubility of three variables was 1.135, 1.315 and 1.591 
respectively. Increasing variable A and B led to an increase in the particle size of microemulsions from 120.08 nm to 188.38 nm and 48.18 nm to 
260.28 nm, respectively. The influence of variable B was quite significant, while variable C has no significant effect on particle size. Quercetin 
microemulsions showed good chemical and functional stability when stored at 4 °C. Under other conditions, especially at 40 °C, the activity of the 
microemulsion is considerably reduced. 
Conclusion: The influence of different variables on the characteristics of microemulsions was complicated. Care must be taken in the composition 
and storage conditions of these formulations. 
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INTRODUCTION 
With the development of the aging society, the anti-aging of the skin 
has always been a topic that has attracted attention. Many studies 
have pointed out that the clinical signs of aging are mainly affected 
by external factors, especially ultraviolet (UV) exposure. Chronic UV 
radiation exposure from the sun has been shown to cause premature 
skin aging (photoaging) and skin cancer; while acute exposure may 
cause sunburn, immune suppression, and connective tissue 
degradation [1, 2]. These skin damages due to ultraviolet radiation 
(UVR) exposure is the result of the generation of free radicals and 
skin inflammation [3]. Although the physical or chemical sunscreens 
can reduce skin damage caused by UVR, their protective effects are 
not satisfactory due to inadequate use, lack of antioxidative and anti-
inflammatory properties, incomplete spectral protection and toxicity 
[4]. A new concept in cosmetics and pharmaceutical research and 
development is to use substances that can protect the skin from UVR 
damage and may also have biological UV filtering activity, which is 
the so-called "biological filters [5]. Some naturally occurring 
compounds, such as quercetin, have been proven to exhibit several 
biological properties, including anti-inflammatory, antiviral, and 
antimicrobial effects [6, 7]. In addition, quercetin not only has a sun 
protection effect by absorbing ultraviolet radiation [8], but also has a 
whitening effect on the skin by inhibiting tyrosinase [9]. It is also a 
good antioxidant and has rejuvenated activity on terminally 
senescent cells [10]. Therefore, the topical preparation of quercetin 
has quite excellent development potential. 
However, the low solubility and low skin penetration ability of 
quercetin limit its application. Different methods have been studied 
for the skin delivery of quercetin [11-13]. Unfortunately, insufficient 
drug loading, large droplet size, and poor stability is often the 
disadvantages of those carrier systems [14-17]. Microemulsions has 
become an attractive technique for the percutaneous administration 
of drugs due to high solubilizing capacity and thermodynamic 
stability [18, 19]. Studies have pointed out that the incorporation of 
quercetin into microemulsions can obtain a more optimized effect 
than that of emulsions [20]. However, microemulsion systems are 
diverse in composition; different pharmaceutical properties such as 
type of microemulsions, the particle size of the dispersion phase, 
stability are influenced by complex process conditions. Detailed 
research is necessary in order to apply these systems to "cosmetic or 
pharmaceutical preparations" [21]. Experimental designs may 
obtain the most information from the fewest experiments [22, 23], 
but there were very few studies on the effect of the composition on 
the properties of quercetin-loaded microemulsion by experimental 
design. Therefore, a two-level factorial experimental design was 
utilized in this study to investigate the influence of the composition 
variables on the production of quercetin-loaded microemulsions, 
and the chemical and functional activity studies of microemulsions 
were also carried out to evaluate the stability of quercetin 
microemulsions. 
MATERIALS AND METHODS 
Materials 
Quercetin, 1,1-diphenyl-2-pycrylhydrazyl (DPPH), tyrosinase, 
isopropyl myristate (IPM) and phosphoric acid were purchased from 
Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). Sorbitan 
monooleate (Span 80®), polyoxyethylene sorbitan monostearate 
(Tween 60®) and polyoxyethylene sorbitan monooleate (Tween 
80®) were from Nippon Shinyaku Co., Ltd. (Kyoto, Japan). Liquid 
chromatography grade methanol was purchased from Macron Fine 
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Chemicals (Avantor Performance Materials, Center Valley, PA, USA). 
All other chemicals were of analytic grade. 
Construction of pseudo-ternary phase diagrams 
The existence zones of microemulsions were determined by 
constructing pseudo-ternary phase diagrams using the water titration 
method. Based on the results obtained, appropriate parameters were 
selected for further experimental design. In this study, IPM was 
selected as an oil phase, Tween 60®/Span 80® (3:2) and ethanol were 
selected as a surfactant and as co-surfactant, and they were firstly 
mixed at the ratio of 1:1 (w/w) to form the mixed surfactant (Smix). 
For the aqueous phase, two different aqueous phases, water or 150 
mmol NaCl solution, were used to prepare microemulsions. 
For each pseudo-ternary phase diagram, the oil mixtures were prepared 
with the weight ratio of oil to Smix at 9.5:0.5, 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 
3:7, 2:8, 1:9, and 0.5:9.5, respectively. To these mixtures, water was 
added drop-wise and mixed thoroughly by magnetic stirrers at room 
temperature. Following the addition of each drop of water, the mixture 
was visually examined for transparency. The titration of water was 
stopped when the turbid mixtures were converted into a transparent 
solution. The amounts of water added in each group were recorded and 
marked on a pseudo ternary phase diagram with one axis representing 
the aqueous phase, the second representing oil, and the third 
representing Smix. Next, use 150 mmol NaCl solution instead of water 
for another comparison. On the basis of the pseudo ternary phase 
diagrams results, the appropriate composition ratio of the 
microemulsions will be selected for the experimental design study [24]. 
23 Full factorial experimental design 
Preparation of microemulsions 
During the preparation of microemulsions, different composition 
ratios will affect the performance of microemulsions. In order to 
determine the influence of manufacturing conditions on product 
characteristics and obtain the optimal manufacturing conditions, 23 
full factorial experimental design was applied [25]. Three 
independent variables in this experiment, the percentage of oil 
phase (variable A), the percentage of Smix (variable B), the type of 
aqueous phase (variable C), were selected to investigate the 
influence on the solubility of quercetin and the particle size of the 
microemulsions. Each variable appears at two appropriate levels 
(low level (-1), high level (+1)), and the value of levels was selected 
based on the results obtained from the pseudo-ternary phase 
diagrams. The experimental variables and the design matrix are 
given in table 1 and table 2. For example, in the first experiment 
(ME-1) shown in table 2, the variables A, B, and C are all low levels; 
that is, the composition of the microemulsion is 28% of the oil phase, 
62% of Smix and 10% of water. Eight different microemulsions were 
carried out in random order according to the preparation method 
described in the previous "Pseudo-Ternary Phase Diagram" section, 
and the properties (solubility and particle size) were tested. 
  
Table 1: Two levels of three variables in 23 full factorial experimental design 
 Variables Low level (-1) High level (+1) 
A: Percentage of oil phase 28% 31% 
B: Percentage of Smix 62% 65% 
C: Type of aqueous phase water NaCl solution 
 
Table 2: A design matrix of 23 full factorial design 
Formulation Independent variables 
A: Percentage of oil phase B: Percentage of Smix C: Type of aqueous phase 
ME-1 -1 -1 -1 
ME-2 +1 -1 -1 
ME-3 -1 +1 -1 
ME-4 +1 +1 -1 
ME-5 -1 -1 +1 
ME-6 +1 -1 +1 
ME-7 -1 +1 +1 
ME-8 +1 +1 +1 
 
Solubility test  
Solubility of quercetin in different microemulsions was determined 
by the shake flask method [26]. An excess of quercetin was added to 
a single vial containing 10 ml of the microemulsion. After sealing, the 
mixture was shaken in a water bath shaker kept at room 
temperature for 72 h. The mixture was centrifuged at 12,000 rpm 
for 5 min and then filtered through a 0.45 μm membrane filter. The 
filtrate was appropriately diluted and quantified by high-
performance liquid chromatography (HPLC). HPLC analyses were 
performed using a Hitachi (Japan) liquid chromatograph equipped 
with a photodiode array detector. Samples were injected manually 
and the separation was performed in a C18 column with a mobile 
phase of methanol/water (60:40, v/v) containing 0.5% phosphoric 
acid and detected at 374 nm [27]. 
Particle size test 
Mean particle size of different microemulsions were determined by were 
determined by using a dynamic light-scattering system [28]. Samples 
were not diluted and the measurements were performed at 25 °C. 
Statistical analysis 
All data were expressed as means±standard deviations (mean±SD). 
Statistically significant differences were identified using the 
student’s t-test with P<0.05 as a minimal level of significance. 
Statistical evaluation of the effects of the factors on the solubility and 
particle size was performed applying one-way analysis of variance 
(ANOVA) at a 0.05 level, using a commercially available software 
package, Design Expert® V. 7.1.3 (Stat-Ease, USA). 
In vitro release studies 
Depending on the results of the experimental design, appropriate 
microemulsions were selected for the in vitro release test. In vitro 
release studies were carried out using modified Franz diffusion cells 
with cellulosic membrane [17]. First, the cellulose membrane was 
fixed between two compartments of the cell (the donor and receptor 
compartment). The receptor medium was filled with 10 ml of pH 7.2 
phosphate-buffered saline (PBS)/Tween 80® (9:1), and was 
constantly stirred by using of magnet stirring at 600 rpm and 37±1 
°C. Microemulsion containing quercetin was placed in the donor part 
and covered to avoid water evaporation. At predetermined time 
periods (5 min, 10 min, 15 min, 20 min, 30 min, 1h, 3h, 6h, 12h and 
24 h), 0.2 ml of sample was withdrawn from the receptor solution 
and replenished with 0.2 ml of freshly prepared buffer. Each sample 
was repeated in triplicate (n=3). Cumulative released drug (W(n)) 
was calculated by the following equation [17]: 
W(n) = C(n) × V + Vi × Ci 
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Where C(n) is the concentration of the drug (mg/ml) determined at 
nth sampling interval, V is the individual Franz diffusion cell volume 
(ml), Ci is the concentration of drug for ith sample (mg/ml), and Vi is 
the sampling volume (ml). 
Dissolution release kinetics 
To study the mechanism of drug release from different 
microemulsions, drug release data were analyzed according to the 
zero-order, first-order, and Higuchi model. The equations were 














Where Qt is the amount of drug released at time t, Q0 is the amount 
of drug released at time t = 0, k0 is the zero-order release constant, k1 
is the first-order release constant, kH is the release constant of 
Higuchi. 
Stability test of microemulsions 
The optimal microemulsion formulations were stored at 4 °C (75% 
R. H.), 30 °C (75% R. H.), 40 °C (75% R. H.), respectively, for 3 mo. 
Chemical properties (the content of quercetin) and functional 
activity (DPPH free radical scavenging ability and inhibition of 
tyrosinase activity) were tested at 0, 1, 2, and 3 mo [31]. 
Chemical stability test 
The microemulsion containing quercetin was diluted in methanol, 
and the mixture was centrifuged at 12,000 rpm for 5 min and then 
filtered through a 0.45 μm membrane filter. The filtrate was 
appropriately diluted and evaluated for quercetin content by HPLC 
method [27]. 
Functional stability test: DPPH free radical scavenging assay 
The antioxidant activity of microemulsions was determined 
according to the modified method previously described by Fenglin 
[32]. The antioxidant activity was measured by the bleaching rate of 
DPPH. In its radical form, DPPH absorbs at the wavelength of 517 
nm, but its absorption decreases upon reduction by an antioxidant 
or a radical compound. The microemulsion (150 μl) was added to 50 
μl of a 0.1 mmol methanol DPPH solution. Methanol without the 
microemulsion was used as a control. The decrease in absorbance 
was determined at 517 nm after 30 min at room temperature in the 
dark. The decrease in the absorbance values of the samples was 
correlated with the control values and then the percentage of DPPH 
scavenging was calculated by the formula below [33]: 
% inhibition = (A0 − Ai) ∕ A0 × 100 
Where A0 and Ai denote the absorbance at 517 nm of the control and 
the test samples. 
Functional stability test: tyrosinase inhibition assay 
The tyrosinase inhibition assay was performed based on a previous 
study with slight modification [34]. Samples were prepared in a 96-
well plate and the components were added as follows: 50 μl 
phosphate buffer (pH 6.8), 100 μl sample and 50 μl L-tyrosine 
solution. After incubation at 37 °C for 10 min, the reaction was 
initiated by adding 20 μl tyrosinase (350 U/ml) to each well and 
incubating at 37 °C for 30 min. The enzyme activity was determined 
by measuring the absorbance at 475 nm. 
The percentage of tyrosinase inhibition was calculated as follows:  
Tyrosinase inhibition(%) = (A − B) − (C − D) ∕ (A − B) × 100 
Where A is the absorbance of the control with the enzyme (L-
tyrosine mixed with the enzyme in the buffer), B is the absorbance of 
the control without the enzyme (L-tyrosine in the buffer), C is the 
absorbance of the test sample with the enzyme (L-tyrosine mixed 
with the enzyme and test sample in the buffer) and D is the 
absorbance of the test sample without the enzyme (L-tyrosine mixed 
with the test sample in the buffer). 
RESULTS AND DISCUSSION 
Pseudo-ternary phase diagrams 
Pseudo-ternary phase diagrams were constructed to determine the 
microemulsion region using the water titration method. This region, 
which is clear and homogenous, shows the range of possible 
concentrations of microemulsion components that can form a single-
phase microemulsion with each other. Two pseudo-ternary phase 
diagrams constructed with different aqueous phases (water and NaCl 
solution) are shown in fig. 1A and fig. 1B respectively. It was obvious that 
by increasing the percentage of Smix, the microemulsion region in the 
phase diagram increased. In addition, by changing the water phase from 
water to NaCl solution, the microemulsion region area extended slightly. 
23Full factorial experimental design 
According to the 23 full factorial experimental design method, three 
kinds of independent variable were selected in this experiment, 
namely variable A (percentage of oil phase), variable B (percentage 
of Smix), and variable C (type of aqueous phase). There are two 
levels for each variable, namely high level [+1] and low level [-1]. 
Two levels of three variables were chosen from each pseudo-ternary 
phase diagram to ensure the achievement of microemulsions (table 
3). The factorial design experiments were performed in random 
order, and the responses were measured as the solubility of 
quercetin and particle size. The design matrix and data obtained 
from a duplicate of the 23 experiments is given in table 3. 
 
Table 3: Physical characteristics of different microemulsions 
Random no. 
(Formulation) 
Independent variables Response＊ 
A: Percentage of oil 
phase 
B: Percentage of 
Smix 
C:  





1 (ME-3) 28% 65% water 7.14±0.25 190.5±1.0 
2 (ME-7) 28% 65% NaCl solution 11.20±0.11 237.5±1.3 
3 (ME-2) 31% 62% water 6.15±0.18 41.5±0.8 
4 (ME-5) 28% 62% NaCl solution 8.20±0.06 31.9±0.7 
5 (ME-4) 31% 65% water 7.82±0.14 296.9±1.9 
6 (ME-8) 31% 65% NaCl solution 12.50±0.20 316.2±1.2 
7 (ME-6) 31% 62% NaCl solution 8.59±0.19 98.9±0.9 
8 (ME-1) 28% 62% water 5.23±0.15 20.4±0.6 
＊Values are expressed as mean±SD (n=3) 
 
Among the eight prescriptions, the solubility of quercetin was 
between 5.23 and 12.50 mg/ml, which was compared with the 
solubility of quercetin in water (0.013 mg/ml) [27] and IPM (0.18 
mg/ml) [17]. Microemulsions significantly improved the solubility of 
quercetin. On the other hand, the particle size distribution of the 
microemulsion ranged from 20.4 to 316.2 nm. These results were 
further analyzed in detail with Design Expert® software to find out 
the variables that have an influence on these properties. A half-
normal plot is a plot of the value of effect estimates against their 
cumulative normal probabilities. The half-normal probability plot is 
Chuo et al. 
Int J Pharm Pharm Sci, Vol 13, Issue 1, 23-35 
26 
shown in fig. 2 and displays all significant factors affecting the 
quercetin solubility and particle size of microemulsions. All of the 
effects that lie along the line are negligible, whereas the significant 
effects lie far from the line. The important effects which influence 
the solubility of quercetin seem to be the main effects of A, B, C and 
the BC interaction which are far from the line (fig. 2A). The statistical 
differences were assessed using the ANOVA test to prove these 






Fig. 1: Pseudo-ternary phase diagrams containing isopropyl myristate as an oily phase, tween 60®/Span 80® (3:2) (surfactant) and 
ethanol (cosurfactant) with smix ratio of 1:1 (A) water as an aqueous phase (B) NaCl solution as an aqueous phase 
 
Table 4: Analysis of variance for solubility 
Source of variation Degrees of 
freedom 
Solubility  
Sum of squares Mean square F Prob＞F＊ 
Model 4 41.52 10.38 140.00 0.0010 
A 1 1.35 1.35 18.25 0.0235 
B 1 13.76 13.76 185.51 0.0009 
C 1 25.03 25.03 337.55 0.0004 
BC 1 1.39 1.39 18.69 0.0228 
Residual 3 0.22 0.074   
Cor total 7 41.74    
＊Significant: P＜0.05 
 
Table 5: Analysis of variance for particle size 
Source of variation Degrees of 
freedom 
Particle size 
Sum of squares Mean square F Prob＞F＊ 
Model 2 99302.60 49651.30 59.32 0.0003 
A 1 9329.78 9329.78 11.16 0.0205 
B 1 89972.82 89972.82 107.49 0.0001 
Residual 5 4180.37 836.07   
Cor total 7 1.035E+005    
＊Significant: P＜0.05 
Chuo et al. 






Fig. 2: The half-normal plot used for identifying all significant effects (A) the effect on quercetin solubility of microemulsions (B) the effect 
on the particle size of microemulsions 
 
As shown in fig. 3A-D, the response value of the effects shows that 
all the effects of the three variables are positive. That is to say that 
increased variables A, B and C led to increasing quercetin 
solubility of microemulsions and exhibited the best results arising 
from the high level of three variables. The influence of variable A is 
less significant among the three variables. For instance, the 
solubility of quercetin of microemulsions at a low level of variable 
A was 6.17 mg/ml, compared to 7.00 mg/ml at a high level of 
variable A. The ratio of the high level to low level for solubility was 
1.135. For variable B and variable C, the solubility of quercetin of 
microemulsions at a low level was 5.69 mg/ml and 6.36 mg/ml, 
compared to 7.48 mg/ml and 10.12 mg/ml, the ratio of the high 
level to low level for solubility was 1.315 and 1.591 respectively. 
Increasing the percentage of oil phase from low level to high level 
only caused a slight increase in the solubility of quercetin of 
microemulsions. Although increasing the percentage of oil phase 
has a positive effect on the solubility of quercetin in 
microemulsion, dissolving or dispersing of quercetin in the 
microemulsion was mainly done into the interfacial layer of 
emulsifying agents (surfactant and co-surfactant) and only small 
quercetin quantity was dispersed into oil phase. Therefore, the 
influence of variable A (percentage of oil phase) (fig. 3A) on the 
solubility of quercetin (fig. 3A) was not as significant as that of 
variable B (percentage of Smix) (fig. 3B). This result is consistent 
with the previous study by Kajbafvala [17]. As for variable C (type 
of aqueous phase), compared to those prepared with water (fig. 
3E), the solubility of quercetin in microemulsions prepared with 
NaCl solution (fig. 3F) significantly increased. This result should be 
due to the fact that the solubility of quercetin in NaCl solution is 
greater than that in water [35]. 
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Fig. 3: Factorial analysis of the effect of individual variables and their interactions on quercetin solubility of microemulsions (A) effect of 
variable A (percentage of oil phase) (B) effect of variable B (percentage of surfactant/co-surfactant) (C) effect of variable C (type of 
aqueous phase) (D) effect of B×C interaction (E) effect of variable A and variable B on solubility (water as an aqueous phase) (F) effect of 
variable A and variable B on solubility (NaCl solution as an aqueous phase) 
Chuo et al. 










Fig. 4: Factorial analysis of the effect of individual variables on particle size of microemulsions (A) effect of variable A (percentage of oil 
phase) (B) effect of variable B (percentage of surfactant/co-surfactant) (C) effect of variable A and variable B on particle size (water as an 
aqueous phase) (D) effect of variable A and variable B on particle size (NaCl solution as an aqueous phase) 
Chuo et al. 
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In addition to identifying individual variables, the interactions are 
the key to getting the optimal conditions. The results obtained from 
the interactions are shown in fig. 3D and can be described as follows. 
From the BC interaction, regardless of whether the variable C (type 
of aqueous phase) was at low level or high level, that is to say 
despite the difference in aqueous phase, increasing the variable B 
(percentage of Smix) will cause the increasing of quercetin solubility. 
Furthermore, the percentage of Smix (variable B) has little effect 
when the aqueous phase (variable C) is at the low level in contrast to 
the high level. Increasing variable B at a low level of variable C 
tended to increase the solubility of quercetin, but the influence was 
minor compared to that at a high level of variable C. Similarly, 
variable C has a more significant effect when variable B is at the high 
level in contrast to the low level. 
On the other hand, the analysis results of particle size are shown in fig. 
2 and fig. 4. The variable A and B are obviously the effective variables 
while variable C has no significant effect on particle size. There is no 
obvious interaction between the three variables. In addition, it can be 
seen in fig. 4 A-D that the two variables have a positive effect on the 
particle size of microemulsions. Increasing the oil phase and the 
percentage of Smix led to an increase in the particle size of 
microemulsions from 120.08 nm to 188.38 nm and 48.18 nm to 
260.28 nm, respectively. The influence of variable B (percentage of 
Smix) is quite significant (fig. 4B). Because the surfactant was 
adsorbed on the interface of the microemulsion droplets, the long 
lipophilic chain of the surfactant might increase the droplet size of the 
microemulsion [17]. Therefore, for variable B (the percentage of 
Smix), the particle size of the microemulsions will increase relatively 
at a larger Smix ratio. Besides, the solubility of quercetin increases by a 
larger percentage of Smix. It can be assumed that more quercetin 
accumulates on the interface layer of the droplet and stays in the 
continuous phase, and larger particles will be produced at higher 
quercetin concentrations [36-38]. This phenomenon can also explain 
the influence of variable A on particle size: increasing the percentage 
of the oil phase will also increase the solubility of the hydrophobic 
quercetin, resulting in an increase in particle size. 
In vitro release studies 
The thermodynamic activity of the drug in the formulation is an 
important driving force for drug release. A high-concentration 
formulation should have a higher thermodynamic activity [39, 40]. 
Therefore, based on the results obtained from the previous 
experimental analysis, the formulations for the maximum solubility 
of quercetin prepared with water and NaCl solution respectively 
(ME-4 and ME-8) were selected and in vitro release studies were 
performed to compare the release of quercetin from the two 
microemulsions. The results obtained are shown in fig. 5. Both 
microemulsions showed good in vitro drug release. The release data 
were analyzed as per zero-order, first-order and Higuchi models. 
The zero-order kinetic model describes the system where the drug 
release rate is only a function of time and independent of its 
concentration. In contrast, the first-order kinetic model is indicative 
of systems where drug release is a concentration-dependent 
process. Higuchi model describes the release of drugs from the 
formulation is proportional to the square root of time. The Higuchi 
model had the best fit with a higher correlation for two formulations 
(fig. 6A and 6B). The release of quercetin was linear when the 
amount released percentage was plotted as a function of the square 
root of time. The correlation coefficients (R2) of Higuchi model were 
0.9796 and 0.9809, respectively. For other kinetic models, the 
correlation coefficients of the zero-order model were 0.8437 and 
0.8573, as well as the first-order model were 0.6645 and 0.6957. 
 
 
Fig. 5: In vitro release profiles of quercetin from two microemulsions (ME-4, ME-8). Values are expressed as mean±SD (n=3) 
 
Stability test 
The stability assessment of the active ingredients in the formulation 
is important for the development of new products. Storage at 
different climatic conditions may affect the effectiveness of the 
product [31, 40]. Chemical stability (change in drug content) studies 
can evaluate the ability of a drug to ensure its efficacy and safety at 
the necessary concentration. However, considering the fact that 
antioxidant formulations could become pro-oxidant or lose its 
activity without apparently altering the drug content, the functional 
stability assessment should be accompanied by chemical stability 
studies to understand whether the anti-oxidation and anti-
tyrosinase activities of quercetin are affected in different storage 
environments [41]. Functional stability guarantees the efficacy of 
products with specific functions. In this study, in addition to 
evaluating the changes in quercetin content of microemulsions 
stored at three different temperatures, two functional stability 
(DPPH scavenging, anti-tyrosinase activity) are also used as another 
method to evaluate the stability of quercetin in microemulsions. 
Fig. 7 shows the change of quercetin content in microemulsions in 
different storage environments, and the quercetin solution is used as 
a reference for comparison. Regarding the stability of the 
microemulsions at different temperatures, the quercetin 
microemulsion stored at 4 °C showed chemical stability during the 
entire experiment (3 mo). The quercetin concentration of 
microemulsion stored at 30 °C decreased slightly, while the 
quercetin concentration of microemulsion stored at 40 °C decreased 
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significantly. However, the quercetin content in the quercetin 
solution stored at different temperatures decreased significantly in 
the first month, and the quercetin content in the third month 
decreased by more than 40%. It can be observed that the 
microemulsion increases the stability of the content over a longer 
period of time, and the quercetin in the microemulsion shows better 
stability than the quercetin solution in three different storage 
environments. Temperature conditions may change the hydrophilic-
lipophilic balance of surfactants and destabilize the surfactant 
interface, affecting the formation of microemulsions and the stability 
of quercetin. This phenomenon can be confirmed by the functional 
stability results, that quercetin microemulsions have better 
functional stability than quercetin solution (fig. 8 and 9). The 
microemulsion maintained its antioxidant and anti-tyrosinase 
activity when stored at 4 °C during the 3 mo of analysis. The 
microemulsions under other conditions, especially 40 °C, had a 
significant decrease of antioxidant and anti-tyrosinase activity. 
Stability of functional activity at 4 °C was better than other storage 
temperatures, which might be due to the fact that quercetin was 
most stable at 4 °C. When comparing the concentration of quercetin 
and antioxidant activity, the reduction in antioxidant activity was 
not as obvious as the reduction in quercetin concentration. These 
differences can be explained by the fact that some of the quercetin 
degradation products may have antioxidant activity. These results 
indicate that care must be taken with the storage conditions of these 






Fig. 6: Fitting experimental data of microemulsions by higuchi release kinetic model (A) ME-4 (B) ME-8, values are expressed as mean±SD 
(n=3) 
 
Chuo et al. 
Int J Pharm Pharm Sci, Vol 13, Issue 1, 23-35 
33 
 
Fig. 7: Chemical stability of quercetin in microemulsions (ME-4, ME-8) and aqueous solution (QS) stored at 4 °C, 30 °C, and 40 °C for 3 mo. 
Values are expressed as mean±SD (n=3) 
 
 
Fig. 8: Antioxidative stability of quercetin in microemulsions (ME-4, ME-8) and aqueous solution (QS) stored at 4 °C, 30 °C, and 40 °C for 3 
mo, values are expressed as mean±SD (n=3) 
 
 
Fig. 9: Anti-tyrosinase stability of quercetin in microemulsions (ME-4, ME-8) and aqueous solution (QS) stored at 4 °C, 30 °C, and 40 °C for 
3 mo, values are expressed as mean±SD (n=3) 
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CONCLUSION 
In this study, the influence of each variable on the characteristics of 
microemulsions was complicated. Increasing the percentage of oil 
phase and the percentage of Smix could increase the solubility of 
quercetin in microemulsions, but it also caused an increase in 
particle size. The type of aqueous phase has a significant effect on 
the solubility of quercetin in microemulsions, but has no apparent 
effect on the particle size of microemulsions. Increasing the 
solubility of quercetin in microemulsions is beneficial to increase the 
drug that can penetrate into the skin, but increasing the particle size 
results in poorer skin penetration. The result demonstrates that 
such details can ascertain critical parameters that have to be 
controlled in order to give optimal formulation. In addition, 
microemulsions could protect the embedded drugs from 
degradation and maintain fine antioxidative and anti-tyrosinase 
activities at an appropriate temperature, which was very useful for 
the development of delivery systems. 
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